HOLX Hologic Inc

$67.82

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 8/19/2025

About Hologic Inc

Hologic, Inc. is a medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging.

Website: https://www.hologic.com

Sector
LIFE SCIENCES
Industry
X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
September
CIK
859737
Address
250 CAMPUS DRIVE, MARLBOROUGH, MA, US
Valuation
Market Cap
$12.99B
P/E Ratio
18.22
PEG Ratio
1.26
Price to Book
2.71
Performance
EPS
$3.16
Dividend Yield
—
Profit Margin
18.40%
ROE
15.80%
Technicals
50D MA
$62.01
200D MA
$73.95
52W High
$84.67
52W Low
$55.89
Fundamentals
Shares Outstanding
226M
Target Price
$76.03
Beta
0.83

HOLX EPS Estimates vs Actual

● Estimated
● Actual

HOLX News & Sentiment

Aug 15, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Is Trending Stock Hologic, Inc. ( HOLX ) a Buy Now?
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Aug 13, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Hologic Eyes Organic Growth Rebound in 2026 on Breast Health Strength
HOLX targets a mid-single-digit organic growth rebound in 2026, powered by Breast Health recovery and new product innovation.
Aug 08, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It?
HOLX's Diagnostics arm eyes long-term growth with new assays, platform expansion and oncology test adoption despite headwinds.
Aug 06, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Should You Buy, Sell or Hold Hologic Stock Post Q3 Earnings?
HOLX rises post earnings beat, fueled by Diagnostics strength and Surgical growth. However, macro headwinds persist.
Aug 05, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Aug 05, 2025 • Zacks Commentary NEUTRAL
Tempus AI Targets Breast Cancer With Expanded Next - AI Platform
TEM expands its AI-driven Tempus Next platform into breast cancer, targeting key testing gaps to improve care delivery.
Sentiment Snapshot

Average Sentiment Score:

0.186
50 articles with scored sentiment

Overall Sentiment:

Bullish

HOLX Reported Earnings

May 01, 2025
Mar 31, 2025 (Post market)
0.01 Surprise
  • Reported EPS: $1.03
  • Estimate: $1.02
  • Whisper: —
  • Surprise %: 1.4%
Feb 05, 2025
Dec 31, 2024 (Post market)
0.01 Surprise
  • Reported EPS: $1.03
  • Estimate: $1.02
  • Whisper: —
  • Surprise %: 1.0%
Nov 04, 2024
Sep 30, 2024 (Post market)
0.0 Surprise
  • Reported EPS: $1.01
  • Estimate: $1.01
  • Whisper: —
  • Surprise %: 0.0%
Jul 29, 2024
Jun 30, 2024 (Post market)
0.04 Surprise
  • Reported EPS: $1.06
  • Estimate: $1.02
  • Whisper: —
  • Surprise %: 3.9%
May 02, 2024
Mar 31, 2024 (Post market)
0.05 Surprise
  • Reported EPS: $1.03
  • Estimate: $0.98
  • Whisper: —
  • Surprise %: 5.1%
Feb 01, 2024
Dec 31, 2023 (Post market)
0.03 Surprise
  • Reported EPS: $0.98
  • Estimate: $0.95
  • Whisper: —
  • Surprise %: 3.2%
Nov 09, 2023
Sep 30, 2023 (Post market)
0.05 Surprise
  • Reported EPS: $0.89
  • Estimate: $0.84
  • Whisper: —
  • Surprise %: 6.0%
Jul 31, 2023
Jun 30, 2023 (Post market)
0.04 Surprise
  • Reported EPS: $0.93
  • Estimate: $0.89
  • Whisper: —
  • Surprise %: 4.5%
May 01, 2023
Mar 31, 2023 (Post market)
0.18 Surprise
  • Reported EPS: $1.06
  • Estimate: $0.88
  • Whisper: —
  • Surprise %: 20.4%

Financials